These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbation. Cydulka RK; Rowe BH; Clark S; Emerman CL; Rimm AR; Camargo CA Acad Emerg Med; 2005 Dec; 12(12):1173-9. PubMed ID: 16282511 [TBL] [Abstract][Full Text] [Related]
7. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers. Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703 [TBL] [Abstract][Full Text] [Related]
8. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276 [TBL] [Abstract][Full Text] [Related]
9. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs. Drescher GS; Carnathan BJ; Imus S; Colice GL Respir Care; 2008 Dec; 53(12):1678-84. PubMed ID: 19025702 [TBL] [Abstract][Full Text] [Related]
10. The effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations. Kodric M; Garuti G; Colomban M; Russi B; Porta RD; Lusuardi M; Confalonieri M Respirology; 2009 Apr; 14(3):424-8. PubMed ID: 19192230 [TBL] [Abstract][Full Text] [Related]
12. [Early supported discharge for patients with exacerbations of chronic obstructive pulmonary disease]. Ringbaek TJ; Nielsen LL; Admasu H; Lange P Ugeskr Laeger; 2008 Jan; 170(1):47-50. PubMed ID: 18208716 [TBL] [Abstract][Full Text] [Related]
13. Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance. Yilmaz R; Gencer M; Ceylan E; Demirbag R J Am Soc Echocardiogr; 2005 Aug; 18(8):873-81. PubMed ID: 16084341 [TBL] [Abstract][Full Text] [Related]
15. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults. Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388 [TBL] [Abstract][Full Text] [Related]
16. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study. Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474 [TBL] [Abstract][Full Text] [Related]
17. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease. Lee TA; Schumock GT; Bartle B; Pickard AS Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009 [TBL] [Abstract][Full Text] [Related]
18. Post-heart transplant diastolic dysfunction is a risk factor for mortality. Tallaj JA; Kirklin JK; Brown RN; Rayburn BK; Bourge RC; Benza RL; Pinderski L; Pamboukian S; McGiffin DC; Naftel DC J Am Coll Cardiol; 2007 Sep; 50(11):1064-9. PubMed ID: 17825716 [TBL] [Abstract][Full Text] [Related]
19. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304 [TBL] [Abstract][Full Text] [Related]
20. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features. Bustamante-Fermosel A; De Miguel-Yanes JM; Duffort-Falcó M; Muñoz J Am J Emerg Med; 2007 Jun; 25(5):515-22. PubMed ID: 17543654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]